Bert H. O’Neil
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 151
- Colorectal Cancer Treatments and Studies 72
- Pancreatic and Hepatic Oncology Research 31
- Cancer Treatment and Pharmacology 31
- Cancer Immunotherapy and Biomarkers 21
-
- Gastric Cancer Management and Outcomes 19
- Co-authors
- Richard M. Goldberg (36 shared papers)Elizabeth Claire Dees (12 shared papers)Sarina A. Piha‐Paul (14 shared papers)Safi Shahda (36 shared papers)Alan P. Venook (21 shared papers)Robert Z. Orlowski (3 shared papers)Peter M. Voorhees (1 shared paper)Heinz‐Josef Lenz (28 shared papers)
- Journals
- Journal of Clinical Oncology (100 papers)Annals of Oncology (20 papers)The Oncologist (10 papers)Cancer Chemotherapy and Pharmacology (8 papers)Clinical Cancer Research (8 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Bert H. O’Neil
245 papers receiving 9.1k citations
Bert H. O’Neil's Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 4.7k
- Hepatology 863
- Cancer Research 1.0k
- Pathology and Forensic Medicine 970
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Bert H. O’Neil
This map shows the geographic impact of Bert H. O’Neil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert H. O’Neil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert H. O’Neil more than expected).
Fields of papers citing papers by Bert H. O’Neil
This network shows the impact of papers produced by Bert H. O’Neil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert H. O’Neil. The network helps show where Bert H. O’Neil may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert H. O’Neil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 258 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028 Hit paper breakdown → | 2018 | 675 |
| 2 | Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas Hit paper breakdown → | 2005 | 504 |
| 3 | Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial Hit paper breakdown → | 2017 | 399 |
| 4 | The proteasome as a target for cancer therapy. | 2003 | 332 |
| 5 | 2010 | 324 | |
| 6 | 2014 | 296 | |
| 7 | 2005 | 291 | |
| 8 | 2007 | 265 | |
| 9 | 2016 | 247 | |
| 10 | 2011 | 234 | |
| 11 | 2017 | 224 | |
| 12 | 2020 | 149 | |
| 13 | 2019 | 127 | |
| 14 | 2019 | 121 | |
| 15 | 2011 | 110 | |
| 16 | 2020 | 102 | |
| 17 | 2016 | 101 | |
| 18 | 2017 | 95 | |
| 19 | 2015 | 94 | |
| 20 | 2012 | 93 |
About Bert H. O’Neil
Bert H. O’Neil is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Hepatology, having authored 258 papers that have together received 9.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (72 papers), Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Pancreatic and Hepatic Oncology Research (31 papers), Cancer Treatment and Pharmacology (31 papers), Cancer Immunotherapy and Biomarkers (21 papers), Colorectal and Anal Carcinomas (19 papers), Gastric Cancer Management and Outcomes (19 papers) and Genetic factors in colorectal cancer (16 papers). The work is most often cited by research in Oncology (4.7k citations), Hepatology (863 citations), Cancer Research (1.0k citations), Pathology and Forensic Medicine (970 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Bert H. O’Neil has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Richard M. Goldberg, Elizabeth Claire Dees, Sarina A. Piha‐Paul, Safi Shahda, Alan P. Venook, Robert Z. Orlowski, Peter M. Voorhees, Heinz‐Josef Lenz, Patrick A. Ott and Hope S. Rugo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Cancer Chemotherapy and Pharmacology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.